glp 1 m Frontiers 1 medications or looking for a natural alternative. Understanding GLP-1 receptor agonists and

The role of the gut in regulating food intake in man Nutr Rev 1994 52 : 110

Disclosures: Grahame Evans: Nothing to Disclose, Xinruo Zhang: Nothing to Disclose, Jennifer Below: Nothing to Disclose, Kari North: Nothing to Disclose, May Hagiwara: Takeda pharmaceuticals: Employee, Chitra Karki: Takeda Development Center Americas, Inc.: Employee, Takeda Development Center Americas, Inc.: Stock - publicly traded company, Tami Nussbaum: Takeda: Employee, Suna Park: Takeda Pharmaceuticals: Employee, Kaili Ren: Nothing to Disclose, Virginia Clark: Nothing to Disclose 2525 DISEASE PROGRESSION IN ADULT PATIENTS WITH ALPHA-1 ANTITRYPSIN DEFICIENCY-ASSOCIATED LIVER CIRRHOSIS: A RETROSPECTIVE COHORT STUDY OF THE US VETERANS AFFAIRS HEALTH DATABASE Dustin Bastaich 1 Bassam Dahman 1 Suna Park 2 May Hagiwara 2 Chitra Karki 2 Tami Nussbaum 2 Raphaella Ferreira 3 Austen Hentschel 4 David Kaplan 5 Andres Samos 4 Binu John 6 , 1 Virginia Commonwealth University, 2 Takeda Development Center Americas, Inc., 3 Larkin Community Hospital, 4 Florida International University, 5 University of Pennsylvania, 6 University of Miami Background: Alpha-1 antitrypsin deficiency (AATD) may manifest as liver and/or lung disease with a variably progressive course

The nausea typically peaks 24 to 48 hours after injection and improves as the week progresses

Here in The Scope studio, we have Dr